Human Reproduction, Vol. 15, No. 4, 806-809,
April 2000
© 2000 European Society of Human Reproduction and Embryology
Vaginal sildenafil (Viagra): a preliminary report of a novel method to improve uterine artery blood flow and endometrial development in patients undergoing IVF
1 Sher Institute for Reproductive Medicine, 3121 S. Maryland Parkway, Suite 300, Las Vegas, Nevada 89109 and 2 Department of Obstetrics and Gynecology, University of Nevada, School of Medicine, Reno, Nevada, USA
Endometrial growth is thought to depend on uterine artery blood flow and the importance of endometrial development on in-vitro fertilization (IVF) outcome has been previously reported. Nitric oxide (NO) relaxes vascular smooth muscle through a cGMP-mediated pathway and NO synthase isoforms have been identified in the uterus. Sildenafil citrate (Viagra), a type 5-specific phosphodiesterase inhibitor, augments the vasodilatory effects of NO by preventing the degradation of cGMP. In this preliminary report we describe the use of vaginal sildenafil to improve uterine artery blood flow and sonographic endometrial appearance in four patients with prior failed assisted reproductive cycles due to poor endometrial response. The uterine artery pulsatility index (PI) was measured in a mock cycle after pituitary down-regulation with Lupron. The PI was decreased after 7 days of sildenafil (indicating increased blood flow) and returned to baseline following treatment with placebo. The combination of sildenafil and oestradiol valerate improved blood flow and endometrial thickness in all patients. These findings were reproduced in an ensuing gonadotrophin-stimulated cycle. Three of the four patients conceived. Although greater numbers of patients and randomized evaluation are needed to validate this treatment, vaginal sildenafil may be effective for improving uterine artery blood flow and endometrial development in IVF patients with prior poor endometrial response.
Key words: endometrium/in-vitro fertilization/sildenafil/uterine artery blood flow
3 To whom correspondence should be addressed
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  E. H. Y. Ng, C. C. W. Chan, O. S. Tang, W. S. B. Yeung, and P. C. Ho Endometrial and subendometrial vascularity is higher in pregnant patients with livebirth following ART than in those who suffer a miscarriage Hum. Reprod., April 1, 2007; 22(4): 1134 - 1141. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N.J. Raine-Fenning, B.K. Campbell, N.R. Kendall, J.S. Clewes, and I.R. Johnson Endometrial and subendometrial perfusion are impaired in women with unexplained subfertility Hum. Reprod., November 1, 2004; 19(11): 2605 - 2614. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. H. Y. Ng, C. C. W. Chan, O. S. Tang, W. S. B. Yeung, and P. C. Ho Comparison of endometrial and subendometrial blood flow measured by three-dimensional power Doppler ultrasound between stimulated and natural cycles in the same patients Hum. Reprod., October 1, 2004; 19(10): 2385 - 2390. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Bartsch, B. Bartlick, and R. Ivell Phosphodiesterase 4 Inhibition Synergizes with Relaxin Signaling to Promote Decidualization of Human Endometrial Stromal Cells J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 324 - 334. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Toda and T. Okamura The Pharmacology of Nitric Oxide in the Peripheral Nervous System of Blood Vessels Pharmacol. Rev., June 1, 2003; 55(2): 271 - 324. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Ohl, C. Lefebvre-Maunoury, C. Wittemer, G. Nisand, M.-C. Laurent, and P. Hoffmann Nitric oxide donors for patients undergoing IVF. A prospective, double-blind, randomized, placebo-controlled trial Hum. Reprod., October 1, 2002; 17(10): 2615 - 2620. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Kelly, P. Sladkevicius, S. Campbell, and G. Nargund Investigation of the infertile couple: a one-stop ultrasound-based approach Hum. Reprod., December 1, 2001; 16(12): 2481 - 2484. [Abstract] [Full Text] [PDF]
|
|